BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 193 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2018. The put-call ratio across all filers is 1.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,000 | -95.8% | 10,000 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $24,000 | -98.8% | 10,000 | -95.5% | 0.00% | -98.3% |
| Q4 2020 | $2,012,000 | +17.8% | 220,449 | +257.9% | 0.06% | -31.0% |
| Q3 2020 | $1,708,000 | +56.3% | 61,600 | -0.5% | 0.08% | +40.0% |
| Q2 2020 | $1,093,000 | +3543.3% | 61,900 | +368.9% | 0.06% | +2900.0% |
| Q1 2020 | $30,000 | -70.9% | 13,200 | -70.1% | 0.00% | -66.7% |
| Q4 2019 | $103,000 | +202.9% | 44,200 | -56.0% | 0.01% | +200.0% |
| Q2 2018 | $34,000 | -67.6% | 100,500 | +294.1% | 0.00% | -60.0% |
| Q1 2018 | $105,000 | +9.4% | 25,500 | +0.4% | 0.01% | +25.0% |
| Q4 2017 | $96,000 | – | 25,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 423,012 | $41,129,000 | 7.43% |
| Eagle Health Investments LP | 133,163 | $12,947,000 | 5.08% |
| DAFNA Capital Management LLC | 207,911 | $20,215,000 | 4.80% |
| Casdin Capital, LLC | 1,550,000 | $150,707,000 | 4.49% |
| SIB LLC | 65,151 | $6,335,000 | 3.72% |
| CADIAN CAPITAL MANAGEMENT, LP | 913,702 | $88,839,000 | 3.29% |
| Integral Health Asset Management, LLC | 117,500 | $11,425,000 | 3.26% |
| Rock Springs Capital Management LP | 746,732 | $72,605,000 | 1.58% |
| Avidity Partners Management LP | 546,000 | $53,088,000 | 1.47% |
| Zebra Capital Management LLC | 12,698 | $1,235,000 | 1.36% |